Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer
Authors:
- 1 February 2021
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (2) , e2037632
Abstract
In 2020, the American Cancer Society reported the largest 1-year decrease in cancer deaths, in large part because of emerging therapeutic developments that prolong time living with advanced cancer.1 These improvements in survival necessitate evidence on how to improve quality of life (QOL) and symptoms, such as dyspnea, among patients with advanced cancer.Keywords
This publication has 34 references indexed in Scilit:
- Symptom Prevalence in Lung and Colorectal Cancer PatientsJournal of Pain and Symptom Management, 2015
- Effects of Prophylactic Subcutaneous Fentanyl on Exercise-Induced Breakthrough Dyspnea in Cancer Patients: A Preliminary Double-Blind, Randomized, Controlled TrialJournal of Pain and Symptom Management, 2014
- A Randomized Crossover Clinical Trial to Evaluate the Efficacy of Oral Transmucosal Fentanyl Citrate in the Treatment of Dyspnea on Exertion in Patients With Advanced CancerAmerican Journal of Hospice and Palliative Medicine®, 2013
- Continuous Subcutaneous Infusion of Compound Oxycodone for the Relief of Dyspnea in Patients With Terminally Ill CancerAmerican Journal of Hospice and Palliative Medicine®, 2012
- Morphine Versus Midazolam as Upfront Therapy to Control Dyspnea Perception in Cancer Patients While Its Underlying Cause Is Sought or TreatedJournal of Pain and Symptom Management, 2010
- A Review of Quality of Care Evaluation for the Palliation of DyspneaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized SalineJournal of Pain and Symptom Management, 2008
- Midazolam as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea Perception in Patients with Advanced CancerJournal of Pain and Symptom Management, 2006
- Nebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary StudyJournal of Pain and Symptom Management, 2005
- Subcutaneous Morphine for Dyspnea in Cancer PatientsAnnals of Internal Medicine, 1993